|
|
|
|
| LEADER |
01730cam a2200469 4500 |
| 001 |
PPN011767464 |
| 003 |
http://www.sudoc.fr/011767464 |
| 005 |
20180607013000.0 |
| 010 |
|
|
|a 0-7817-0143-0
|
| 020 |
|
|
|a US
|b 9412397
|
| 035 |
|
|
|a (OCoLC)490088645
|
| 035 |
|
|
|a ocm30437188
|
| 035 |
|
|
|a sib0628040
|
| 100 |
|
|
|a 19950504d1994 k y0frey0103 ba
|
| 101 |
0 |
|
|a eng
|
| 102 |
|
|
|a US
|
| 105 |
|
|
|a y z 00|yy
|
| 106 |
|
|
|a r
|
| 200 |
1 |
|
|a Clinical evaluation of psychotropic drugs
|b Texte imprimé
|e principles and guidelines
|f ed. Robert F. Prien, Donald S. Robinson
|g in association with the NIMH and the ACNP
|
| 210 |
|
|
|a New York
|c Raven press
|d 1994
|
| 215 |
|
|
|a 1 vol. (XXI-728 p.)
|d 24 cm
|
| 606 |
|
|
|3 PPN027241742
|a Psychotropes
|2 rameau
|
| 606 |
|
|
|3 PPN02728204X
|a Psychopharmacologie
|2 rameau
|
| 606 |
|
|
|3 PPN02728204X
|a Psychopharmacologie
|3 PPN027315754
|x Recherche
|2 rameau
|
| 606 |
|
|
|3 PPN040683613
|a Essais cliniques comme sujet
|2 fmesh
|
| 606 |
|
|
|3 PPN040696782
|a Évaluation de médicament
|3 PPN040739619
|x méthodes
|2 fmesh
|
| 606 |
|
|
|3 PPN040767892
|a Psychoanaleptiques
|2 fmesh
|
| 676 |
|
|
|a 616.89/18
|v 20
|
| 680 |
|
|
|a RC483
|b .C5355 1994
|
| 686 |
|
|
|a 1994 K-470
|2 usnlm
|
| 686 |
|
|
|a WM 402
|b C6403 1994
|2 usnlm
|
| 702 |
|
1 |
|3 PPN113511655
|a Prien
|b Robert F.
|4 340
|
| 702 |
|
1 |
|3 PPN113511418
|a Robinson
|b Donald S.
|4 340
|
| 712 |
0 |
2 |
|3 PPN027915190
|a National institute of mental health
|c Etats-Unis
|4 340
|
| 712 |
0 |
2 |
|3 PPN032282265
|a American college of neuropsychopharmacology
|4 340
|
| 801 |
|
1 |
|a US
|b OCLC
|g AACR2
|
| 801 |
|
2 |
|a FR
|b AUROC
|g AFNOR
|
| 801 |
|
3 |
|a FR
|b SF
|g AFNOR
|
| 801 |
|
3 |
|a FR
|b Abes
|c 20070326
|g AFNOR
|
| 930 |
|
|
|5 441092101:303879025
|b 441092101
|a 11176
|j u
|
| 979 |
|
|
|a SAN
|
| 998 |
|
|
|a 214280
|
Nantilus
